article · QJM
Abstract Objective This study was conducted to delineate the beneficial effect of Nigella Sativa (NS) on the development and progression of diabetic kidney disease. Methods Rats were allocated into 3 groups: control, T2D (type 2 diabetes), and T2D-NS-treated group. Animals were assessed for renal function, lipid profile, fasting glucose, insulin resistance, RT-qPCR was used to detect mRNA of AMPK, PI3K, AKT, mTOR, HIF-1α, and VEGF, and histopathological analysis was conducted using H&E staining. Results T2D group showed a significant elevation in the blood glucose, insulin, HbA1C, renal function tests, microalbuminuria as well as marked dyslipidemia compared to the control. Moreover, there were an increase in the expressional level of PI3K, AKT, mTOR, HIF-1α, and VEGF and downward regulation of AMPK associated with histopathological deleterious changes. NS treatment ameliorated the biochemical, and histopathological changes to comparable levels with the control. Conclusion NS exerted a clear antidiabetic, antihyperlipidemic, and renoprotective effect in T2D.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/qjmed/hcae175.870
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.